SEC Form 4 · accession 0001179110-19-001744

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Legal Officer, Secretary

Period of report

Feb 8, 2019

Accepted (ET)

Feb 12, 2019 · 4:04 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 8, 2019	M	2,734	$8.71	A	2,934	D
Common Stock	Feb 8, 2019	M	455	$9.60	A	3,389	D
Common Stock	Feb 8, 2019	M	914	$12.21	A	4,303	D
Common Stock	Feb 8, 2019	M	1,447	$22.30	A	5,750	D
Common Stock^F1	Feb 8, 2019	S	5,550	$61.69	D	200	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F2	$8.71	Feb 8, 2019	M	2,734	D	—	Feb 25, 2025	Common Stock	2,734	2,734	D
Employee Stock Option (right to buy)^F3	$9.60	Feb 8, 2019	M	455	D	—	May 29, 2025	Common Stock	455	1,823	D
Employee Stock Option (right to buy)^F4	$12.21	Feb 8, 2019	M	914	D	—	Mar 7, 2026	Common Stock	914	11,876	D
Employee Stock Option (right to buy)^F5	$22.30	Feb 8, 2019	M	1,447	D	—	Mar 3, 2027	Common Stock	1,447	36,168	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018.
F2The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter
F3The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
F4The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
F5The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.